Showing results (31-40 of 52) with videos related to
Sort By:
Pageof 6
Journal of Acquired Immune Deficiency Syndromes (1999)|August 15, 2022
Dynamics of Total and Intact HIV-1 DNA in Virologically Suppressed Patients Switching to DTG-Based or ATV-Based Dual TherapyFilippo Dragoni, Barbara Rossetti, Francesca Lombardi, et al.Antimicrobial Agents and Chemotherapy|April 15, 2026
Seminal plasma concentrations of long-acting cabotegravir in men receiving HIV pre-exposure prophylaxisDavide Moschese, Chiara Fusetti, Samuel Lazzarin, et al.AIDS and Behavior|June 8, 2025
High Rates of Drug Use and Chemsex Among PrEP Users and People with HIV in Milan Highlight Need for Targeted InterventionsChiara Fusetti, Enrico Caruso, Andrea Giacomelli, et al.The Journal of Antimicrobial Chemotherapy|October 31, 2024
Comparing the long-term effectiveness and safety of dolutegravir/lamivudine versus bictegravir/emtricitabine/tenofovir alafenamide fumarate as first-line regimens: a real life multicentre cohortArturo Ciccullo, Gianmaria Baldin, Adriana Cervo, et al.Journal of Medical Virology|August 21, 2024
Anal HPV prevalence in individuals with and without other concomitant sexually transmitted infectionsAlberto Rizzo, Davide Moschese, Federica Salari, et al.AIDS Research and Human Retroviruses|December 16, 2020
Risk of Tumor Onset in HIV+ Patients on Two-Drug Regimens: A Cohort Study in an Italian HospitalAlberto Borghetti, Stefania Bellino, Francesca Lombardi, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 3, 2025
Mental health, stigma and risk perception among early adopters of HIV PrEP with LA Cabotegravir in Italy: a multicenter cross-sectional and implementation studyGiulia Del Duca, Davide Moschese, Martina Maresca, et al.International Journal of Antimicrobial Agents|July 14, 2026
Rapid Achievement of Protective Cabotegravir Concentrations in a real-world HIV PrEP cohortDavide Moschese, Chiara Fusetti, Samuel Lazzarin, et al.Emerging Microbes & Infections|April 4, 2024
Evaluation of analytical performance of the STANDARDTM M10 MPX/OPX assay for the simultaneous DNA detection and clade attribution of Monkeypox virusAlessandro Mancon, Angelo Roberto Raccagni, Gloria Gagliardi, et al.Journal of Medical Virology|January 10, 2024
High prevalence of high-risk HPV genotypes in individuals attending an infectious diseases clinic from 2018 to 2022 in Milan, ItalyAlberto Rizzo, Davide Moschese, Federica Salari, et al.Pageof 6